HuMax-Inflam/MDX-018: Phase I/II data

In a dose-escalation Phase I/II trial in 31

Read the full 84 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE